APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Malarial Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-Malarial Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchAnti-Malarial Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Malarial Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Anti-Malarial Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Malarial Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Malarial Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Anti-Malarial Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Malarial Drug include Alvizia, F. Hoffmann-La Roche, Ipca, Ranbaxy, Zydus Cadila, Bayer, GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-Malarial Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Malarial Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Malarial Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Malarial Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Malarial Drug Segment by Company

Alvizia

F. Hoffmann-La Roche

Ipca

Ranbaxy

Zydus Cadila

Bayer

GlaxoSmithKline

Pfizer

Merck

Novartis

Anti-Malarial Drug Segment by Type

Plasmodium Falciparum

Plasmodium Vivax

Plasmodium Ovale

Plasmodium Malariae

Anti-Malarial Drug Segment by Application

E-Commerce

Retail Pharmacy

Hospital Pharmacy

Others

Anti-Malarial Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Malarial Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Malarial Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Malarial Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-Malarial Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Malarial Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-Malarial Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-Malarial Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-Malarial Drug Industry Trends Table 2. Anti-Malarial Drug Industry Drivers Table 3. Anti-Malarial Drug Industry Opportunities and Challenges Table 4. Anti-Malarial Drug Industry Restraints Table 5. Global Anti-Malarial Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-Malarial Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-Malarial Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Anti-Malarial Drug Sales Market Share by Manufacturers Table 9. Global Anti-Malarial Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Anti-Malarial Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-Malarial Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-Malarial Drug Manufacturers, Product Type & Application Table 13. Global Anti-Malarial Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-Malarial Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plasmodium Falciparum Table 17. Major Manufacturers of Plasmodium Vivax Table 18. Major Manufacturers of Plasmodium Ovale Table 19. Major Manufacturers of Plasmodium Malariae Table 20. Global Anti-Malarial Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Anti-Malarial Drug Sales by Type (2021-2026) & (K Units) Table 22. Global Anti-Malarial Drug Sales by Type (2027-2032) & (K Units) Table 23. Global Anti-Malarial Drug Sales Market Share by Type (2021-2026) Table 24. Global Anti-Malarial Drug Sales Market Share by Type (2027-2032) Table 25. Global Anti-Malarial Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Anti-Malarial Drug Revenue by Type (2021-2026) & (K Units) Table 27. Global Anti-Malarial Drug Revenue by Type (2027-2032) & (K Units) Table 28. Global Anti-Malarial Drug Revenue Market Share by Type (2021-2026) Table 29. Global Anti-Malarial Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of E-Commerce Table 31. Major Manufacturers of Retail Pharmacy Table 32. Major Manufacturers of Hospital Pharmacy Table 33. Major Manufacturers of Others Table 34. Global Anti-Malarial Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Anti-Malarial Drug Sales by Application (2021-2026) & (K Units) Table 36. Global Anti-Malarial Drug Sales by Application (2027-2032) & (K Units) Table 37. Global Anti-Malarial Drug Sales Market Share by Application (2021-2026) Table 38. Global Anti-Malarial Drug Sales Market Share by Application (2027-2032) Table 39. Global Anti-Malarial Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Anti-Malarial Drug Revenue by Application (2021-2026) & (K Units) Table 41. Global Anti-Malarial Drug Revenue by Application (2027-2032) & (K Units) Table 42. Global Anti-Malarial Drug Revenue Market Share by Application (2021-2026) Table 43. Global Anti-Malarial Drug Revenue Market Share by Application (2027-2032) Table 44. Global Anti-Malarial Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Anti-Malarial Drug Sales by Region (2021-2026) & (K Units) Table 46. Global Anti-Malarial Drug Sales Market Share by Region (2021-2026) Table 47. Global Anti-Malarial Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Anti-Malarial Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Anti-Malarial Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 51. North America Anti-Malarial Drug Sales by Country (2027-2032) & (K Units) Table 52. Europe Anti-Malarial Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 54. Europe Anti-Malarial Drug Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Anti-Malarial Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Anti-Malarial Drug Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Anti-Malarial Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Anti-Malarial Drug Sales by Country (2027-2032) & (K Units) Table 61. Global Anti-Malarial Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Anti-Malarial Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Anti-Malarial Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Anti-Malarial Drug Revenue Market Share by Region (2021-2026) Table 65. Global Anti-Malarial Drug Revenue Market Share by Region (2027-2032) Table 66. Alvizia Company Information Table 67. Alvizia Business Overview Table 68. Alvizia Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Alvizia Anti-Malarial Drug Product Portfolio Table 70. Alvizia Recent Development Table 71. F. Hoffmann-La Roche Company Information Table 72. F. Hoffmann-La Roche Business Overview Table 73. F. Hoffmann-La Roche Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolio Table 75. F. Hoffmann-La Roche Recent Development Table 76. Ipca Company Information Table 77. Ipca Business Overview Table 78. Ipca Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Ipca Anti-Malarial Drug Product Portfolio Table 80. Ipca Recent Development Table 81. Ranbaxy Company Information Table 82. Ranbaxy Business Overview Table 83. Ranbaxy Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Ranbaxy Anti-Malarial Drug Product Portfolio Table 85. Ranbaxy Recent Development Table 86. Zydus Cadila Company Information Table 87. Zydus Cadila Business Overview Table 88. Zydus Cadila Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Zydus Cadila Anti-Malarial Drug Product Portfolio Table 90. Zydus Cadila Recent Development Table 91. Bayer Company Information Table 92. Bayer Business Overview Table 93. Bayer Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Bayer Anti-Malarial Drug Product Portfolio Table 95. Bayer Recent Development Table 96. GlaxoSmithKline Company Information Table 97. GlaxoSmithKline Business Overview Table 98. GlaxoSmithKline Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. GlaxoSmithKline Anti-Malarial Drug Product Portfolio Table 100. GlaxoSmithKline Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Pfizer Anti-Malarial Drug Product Portfolio Table 105. Pfizer Recent Development Table 106. Merck Company Information Table 107. Merck Business Overview Table 108. Merck Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Merck Anti-Malarial Drug Product Portfolio Table 110. Merck Recent Development Table 111. Novartis Company Information Table 112. Novartis Business Overview Table 113. Novartis Anti-Malarial Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Novartis Anti-Malarial Drug Product Portfolio Table 115. Novartis Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Anti-Malarial Drug Distributors List Table 119. Anti-Malarial Drug Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Anti-Malarial Drug Product Image Figure 2. Global Anti-Malarial Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Malarial Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Malarial Drug Sales (2021-2032) & (K Units) Figure 5. Global Anti-Malarial Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-Malarial Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plasmodium Falciparum Image Figure 9. Plasmodium Vivax Image Figure 10. Plasmodium Ovale Image Figure 11. Plasmodium Malariae Image Figure 12. Global Anti-Malarial Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Anti-Malarial Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Anti-Malarial Drug Sales Market Share by Type (2021-2032) Figure 15. Global Anti-Malarial Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Anti-Malarial Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-Malarial Drug Revenue Market Share by Type (2021-2032) Figure 18. E-Commerce Image Figure 19. Retail Pharmacy Image Figure 20. Hospital Pharmacy Image Figure 21. Others Image Figure 22. Global Anti-Malarial Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Anti-Malarial Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Anti-Malarial Drug Sales Market Share by Application (2021-2032) Figure 25. Global Anti-Malarial Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Anti-Malarial Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Anti-Malarial Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Anti-Malarial Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Anti-Malarial Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Anti-Malarial Drug Sales Market Share by Country (2021-2032) Figure 42. China Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Anti-Malarial Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Anti-Malarial Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Anti-Malarial Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Anti-Malarial Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Anti-Malarial Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Anti-Malarial Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Anti-Malarial Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Anti-Malarial Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Anti-Malarial Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Anti-Malarial Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Anti-Malarial Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Anti-Malarial Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Anti-Malarial Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Anti-Malarial Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Plasmodium Ovale
  • Plasmodium Malariae
Applications
  • E-Commerce
  • Retail Pharmacy
  • Hospital Pharmacy
  • Others
Companies covered
  • Alvizia
  • F. Hoffmann-La Roche
  • Ipca
  • Ranbaxy
  • Zydus Cadila
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-Malarial Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-Malarial Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-Malarial Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-Malarial Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-Malarial Drug Market Dynamics
  1. 2.1 Anti-Malarial Drug Industry Trends
  2. 2.2 Anti-Malarial Drug Industry Drivers
  3. 2.3 Anti-Malarial Drug Industry Opportunities and Challenges
  4. 2.4 Anti-Malarial Drug Industry Restraints
3 Anti-Malarial Drug Market by Manufacturers
  1. 3.1 Global Anti-Malarial Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-Malarial Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-Malarial Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-Malarial Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Malarial Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-Malarial Drug Manufacturers, Product Type & Application
  7. 3.7 Global Anti-Malarial Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Malarial Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Malarial Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Malarial Drug Tier 1, Tier 2, and Tier 3
4 Anti-Malarial Drug Market by Type
  1. 4.1 Anti-Malarial Drug Type Introduction
  2. 4.1.1 Plasmodium Falciparum
  3. 4.1.2 Plasmodium Vivax
  4. 4.1.3 Plasmodium Ovale
  5. 4.1.4 Plasmodium Malariae
  6. 4.2 Global Anti-Malarial Drug Sales by Type
  7. 4.2.1 Global Anti-Malarial Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Anti-Malarial Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Anti-Malarial Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Anti-Malarial Drug Revenue by Type
  11. 4.3.1 Global Anti-Malarial Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Anti-Malarial Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Anti-Malarial Drug Revenue Market Share by Type (2021-2032)
5 Anti-Malarial Drug Market by Application
  1. 5.1 Anti-Malarial Drug Application Introduction
  2. 5.1.1 E-Commerce
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Anti-Malarial Drug Sales by Application
  7. 5.2.1 Global Anti-Malarial Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anti-Malarial Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Anti-Malarial Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Anti-Malarial Drug Revenue by Application
  11. 5.3.1 Global Anti-Malarial Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Anti-Malarial Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Anti-Malarial Drug Revenue Market Share by Application (2021-2032)
6 Global Anti-Malarial Drug Sales by Region
  1. 6.1 Global Anti-Malarial Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Malarial Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-Malarial Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-Malarial Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-Malarial Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-Malarial Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-Malarial Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-Malarial Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-Malarial Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-Malarial Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-Malarial Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-Malarial Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-Malarial Drug Revenue by Region
  1. 7.1 Global Anti-Malarial Drug Revenue by Region
  2. 7.1.1 Global Anti-Malarial Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-Malarial Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-Malarial Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-Malarial Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-Malarial Drug Revenue (2021-2032)
  8. 7.2.2 North America Anti-Malarial Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-Malarial Drug Revenue (2021-2032)
  11. 7.3.2 Europe Anti-Malarial Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-Malarial Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-Malarial Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-Malarial Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-Malarial Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alvizia
  2. 8.1.1 Alvizia Company Information
  3. 8.1.2 Alvizia Business Overview
  4. 8.1.3 Alvizia Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alvizia Anti-Malarial Drug Product Portfolio
  6. 8.1.5 Alvizia Recent Developments
  7. 8.2 F. Hoffmann-La Roche
  8. 8.2.1 F. Hoffmann-La Roche Company Information
  9. 8.2.2 F. Hoffmann-La Roche Business Overview
  10. 8.2.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolio
  12. 8.2.5 F. Hoffmann-La Roche Recent Developments
  13. 8.3 Ipca
  14. 8.3.1 Ipca Company Information
  15. 8.3.2 Ipca Business Overview
  16. 8.3.3 Ipca Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ipca Anti-Malarial Drug Product Portfolio
  18. 8.3.5 Ipca Recent Developments
  19. 8.4 Ranbaxy
  20. 8.4.1 Ranbaxy Company Information
  21. 8.4.2 Ranbaxy Business Overview
  22. 8.4.3 Ranbaxy Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ranbaxy Anti-Malarial Drug Product Portfolio
  24. 8.4.5 Ranbaxy Recent Developments
  25. 8.5 Zydus Cadila
  26. 8.5.1 Zydus Cadila Company Information
  27. 8.5.2 Zydus Cadila Business Overview
  28. 8.5.3 Zydus Cadila Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zydus Cadila Anti-Malarial Drug Product Portfolio
  30. 8.5.5 Zydus Cadila Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Anti-Malarial Drug Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Anti-Malarial Drug Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Anti-Malarial Drug Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Anti-Malarial Drug Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Anti-Malarial Drug Product Portfolio
  60. 8.10.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-Malarial Drug Value Chain Analysis
  2. 9.1.1 Anti-Malarial Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-Malarial Drug Production Mode & Process
  6. 9.2 Anti-Malarial Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-Malarial Drug Distributors
  9. 9.2.3 Anti-Malarial Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst